ArticleFrontiers in immunology2022

A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™).

Fethi Gül et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.